Pegylated liposomal doxorubicin hydrochloride (PLD) for advanced sarcomas in children: preliminary results.
Muñoz
Arturo
A
Department of Pediatrics, Hospital Ramón y Cajal, Alcalá University, Madrid, Spain. amvillatv@yahoo.es
Maldonado
M
M
Pardo
N
N
Fernández
J M
JM
Vela
E
E
Cubells
J
J
D000293:Adolescent; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D002675:Child, Preschool; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D011092:Polyethylene Glycols / Q000009:adverse effects / Q000627:therapeutic use*; D012509:Sarcoma / Q000188:drug therapy*; D016896:Treatment Outcome
D000903:Antibiotics, Antineoplastic; D011092:Polyethylene Glycols; D004317:Doxorubicin